Results 121 to 130 of about 308,152 (267)
Generalized Linear Models for Flexible Parametric Modeling of the Hazard Function. [PDF]
Kearns B +3 more
europepmc +1 more source
ABSTRACT Background Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.
Rawan Korman +10 more
wiley +1 more source
ABSTRACT Ewing sarcoma (ES) and rhabdomyosarcoma (RMS) are aggressive malignancies in children and adolescents where metastases impact prognosis. 18F‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography/computed tomography (FDG‐PET/CT) and bone marrow aspirate and trephine biopsies (BMAT) are used to identify disease involvement.
Imogen Andrews +3 more
wiley +1 more source
Prostate cancer survival estimates: An application with piecewise hazard function derivation. [PDF]
Bhattacharjee A, Budukh A, Dikshit R.
europepmc +1 more source
Temporal Patterns of Air Leak Resolution in Secondary Spontaneous Pneumothorax: A Hazard Function Analysis for Optimal Intervention Timing. [PDF]
Takeyama R +7 more
europepmc +1 more source
A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho +7 more
wiley +1 more source
Dynamic survival analysis: Modelling the hazard function via ordinary differential equations. [PDF]
Christen JA, Rubio FJ.
europepmc +1 more source
On Estimation of the Hazard Function from Population-based Case-Control Studies. [PDF]
Hsu L, Gorfine M, Zucker DM.
europepmc +1 more source
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
Hazard function analysis of prognosis after recurrent colorectal cancer. [PDF]
Ise I +8 more
europepmc +1 more source

